The Prevalence of Extra-cranial Carotid Artery Disease in Chronic Heart Failure

References (37)

1. 1 The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure [DOI]
2. 2 Heart Disease and Stroke Statistics—2010 Update [DOI]
3. 3 Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults [DOI]
4. 4 Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis [DOI]
5. 5 Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial [DOI]
6. 6 Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial [DOI]
7. 7 Association of Coronary Heart Disease Incidence with Carotid Arterial Wall Thickness and Major Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993 [DOI]
8. 8 Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme [DOI]
9. 9 Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis [DOI]
10. 10 Lifetime Risk for Developing Congestive Heart Failure [DOI]
11. 11 Atherosclerotic Disease of the Aortic Arch and the Risk of Ischemic Stroke [DOI]
12. 12 Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm [DOI]
13. 13 Prevalence of Asymptomatic Carotid Artery Stenosis in the General Population [DOI]
14. 14 The Warfarin/Aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure [DOI]
15. 15 Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure [DOI]
16. 16 Long Term Vagal Stimulation in Patients with Advanced Heart Failure First Experience in Man [DOI]
17. 17 Ejection Fraction and Risk of Thromboembolic Events in Patients With Systolic Dysfunction and Sinus Rhythm: Evidence for Gender Differences in the Studies of Left Ventricular Dysfunction Trials [DOI]
18. 18 Management of atherosclerotic carotid artery disease: Clinical practice guidelines of the Society for Vascular Surgery [DOI]
19. 19 Stroke Complicating Percutaneous Coronary Interventions [DOI]
20. 20 Heart failure and the risk of stroke: the Rotterdam Study [DOI]
21. 21 Chronic Baroreflex Activation: A Potential Therapeutic Approach to Heart Failure With Preserved Ejection Fraction [DOI]
22. 22 Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects [DOI]
23. 23 Vascular risks of asymptomatic carotid stenosis. [DOI]
24. 24 NATURAL HISTORY OF ASYMPTOMATIC EXTRACRANIAL ARTERIAL DISEASE [DOI]
25. 25 Incidence of thromboembolic events in congestive heart failure
26. 26 Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population [DOI]
27. 27 Incidence, Predictive Factors, and Prognostic Significance of Supraventricular Tachyarrhythmias in Congestive Heart Failure [DOI]
28. 28 The Incidence of Ischemic Stroke in Chronic Heart Failure: A Meta-Analysis [DOI]
29. 29 Atrial fibrillation and stroke: clinical presentation of cardioembolic versus atherothrombotic infarction [DOI]
30. 30 Carotid wall thickness and stroke risk in patients with asymptomatic internal carotid stenosis [DOI]
31. 31 Natural history of asymptomatic carotid plaque [DOI]
32. 32 Lack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. [DOI]
33. 33 Carvedilol Protects Better Against Vascular Events Than Metoprolol in Heart Failure [DOI]
34. 34 Blood Pressure and Stroke in Heart Failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study [DOI]
35. 35 Spectrum and outcome of congestive heart failure in a hospitalized population [DOI]
36. 36 Risk of arterial ambolization in 224 patients awaiting cardiac transplantation [DOI]
37. 37 Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: Rationale, design, and baseline characteristics of patients in the losartan heart failure survival study-ELITE II [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Clinical Representativeness of the PARADIGM-HF Study in an Outpatient Cohort of Patients with Heart Failure, Including Chagas Disease, Treated According to Guideline-directed Medical Therapy: Prospective Study, in a Single Center in Brazil — shares topic coverage
• Influence of Short Term Exercise on the Quality of Life of Patients with Chronic Heart Failure: Case Series from Saudi Arabia — shares topic coverage
• Tricuspid Annular Plane Systolic Excursion/Pulmonary Arterial Systolic Pressure Ratio as a Predictor of Mortality in Heart Failure Patients — shares topic coverage
• Healthcare Policy for Patients with Chronic Heart Failures at Nam Dinh General Hospital in Vietnam — shares topic coverage
• Therapeutic Itinerary of Patients with Chronic Heart Failure at the Bafoussam Regional Hospital, West Region, Cameroon — shares topic coverage